2022
Perioperative opioid dispensing and persistent use after benign hysterectomy: a systematic review and meta-analysis
Hessami K, Welch J, Frost A, AlAshqar A, Arian S, Gough E, Borahay M. Perioperative opioid dispensing and persistent use after benign hysterectomy: a systematic review and meta-analysis. American Journal Of Obstetrics And Gynecology 2022, 229: 23-32.e3. PMID: 36539027, PMCID: PMC10276170, DOI: 10.1016/j.ajog.2022.12.015.Peer-Reviewed Original ResearchConceptsPersistent opioid useOpioid useBenign hysterectomyHysterectomy routeOpioid dispensingsAbdominal hysterectomyVaginal hysterectomyBack painAlcohol useDosage of opioidsEquivalents of opioidsRoute of hysterectomyYounger patient ageRandom-effects modelWeb of SciencePerioperative opioidsPatient agePerioperative periodSecondary outcomesPrimary outcomeHysterectomyOpioidsHigh riskOperative complexityStudy inception
2020
Toxic Shock Syndrome after Surgery: Case Presentation and Systematic Review of the Literature
Celie KB, Colen DL, Kovach SJ. Toxic Shock Syndrome after Surgery: Case Presentation and Systematic Review of the Literature. Plastic & Reconstructive Surgery Global Open 2020, 8: e2499. PMID: 33133879, PMCID: PMC7572075, DOI: 10.1097/gox.0000000000002499.Peer-Reviewed Original ResearchToxic shock syndromePostoperative toxic shock syndromeShock syndromeSystematic reviewYounger patient ageMeta-Analyses (PRISMA) guidelinesPreferred Reporting ItemsPatient agePermanent complicationsPostoperative patientsSeptic shockPostoperative woundPrompt explorationFatal causeInclusion criteriaIndividual patientsHigh indexReporting ItemsSurgeon awarenessCase presentationPatient healthPatientsSyndromeSurgerySurgeons
2017
Oncologists’ experiences with goals of care conversations.
Smith C, Solomon R, Lin J, Feder S, Bickell N, Schulman-Green D. Oncologists’ experiences with goals of care conversations. Journal Of Clinical Oncology 2017, 35: 50-50. DOI: 10.1200/jco.2017.35.31_suppl.50.Peer-Reviewed Original ResearchGOC conversationsGOC discussionsCare conversationsYounger patient ageGoals of careActive patient participationCommunication training interventionsASCO guidelinesEnd of lifePatient ageAdvanced cancerCare discussionsPatient's failurePatients' beliefsOncologists' experiencesTreatment goalsPatient participationCancer severityCare plansRural hospitalsOncologistsPatientsCommunication interventionsInterpretive descriptionTraining interventionHospital Readmissions among Commercially Insured and Medicare Advantage Beneficiaries with Diabetes and the Impact of Severe Hypoglycemic and Hyperglycemic Events
McCoy RG, Lipska KJ, Herrin J, Jeffery MM, Krumholz HM, Shah ND. Hospital Readmissions among Commercially Insured and Medicare Advantage Beneficiaries with Diabetes and the Impact of Severe Hypoglycemic and Hyperglycemic Events. Journal Of General Internal Medicine 2017, 32: 1097-1105. PMID: 28685482, PMCID: PMC5602759, DOI: 10.1007/s11606-017-4095-x.Peer-Reviewed Original ResearchConceptsDiabetes Complications Severity IndexSevere dysglycemiaIndex hospitalizationMedicare Advantage beneficiariesRisk factorsBetter care transitionsComplications Severity IndexPost-discharge managementIndependent risk factorYounger patient ageOptumLabs Data WarehouseStrong risk factorYears of ageBackgroundHospital readmissionsDesignRetrospective analysisCause readmissionUnplanned readmissionPatient agePrior hospitalizationReadmission ratesYounger patientsHeart failureHospital readmissionSevere hypoglycemiaDiabetes complicationsActive Surveillance in Younger Men With Prostate Cancer
Leapman MS, Cowan JE, Nguyen HG, Shinohara KK, Perez N, Cooperberg MR, Catalona WJ, Carroll PR. Active Surveillance in Younger Men With Prostate Cancer. Journal Of Clinical Oncology 2017, 35: jco.2016.68.005. PMID: 28346806, PMCID: PMC5466007, DOI: 10.1200/jco.2016.68.0058.Peer-Reviewed Original ResearchConceptsBiopsy-based Gleason scoreActive surveillanceAssociation of ageProstate cancerDefinitive treatmentRadical prostatectomyYounger patientsGleason scoreMultivariable Cox proportional hazards regressionYounger ageLow-risk prostate cancerCox proportional hazards regressionGleason score upgradeInitial active surveillanceRelated end pointsCox regression analysisKaplan-Meier methodYounger patient ageProportional hazards regressionPrimary study objectiveInitial biopsyMedian agePatient ageHazards regressionBiochemical outcomes
2015
Neoadjuvant Chemotherapy for Breast Cancer Increases the Rate of Breast Conservation: Results from the National Cancer Database
Killelea BK, Yang VQ, Mougalian S, Horowitz NR, Pusztai L, Chagpar AB, Lannin DR. Neoadjuvant Chemotherapy for Breast Cancer Increases the Rate of Breast Conservation: Results from the National Cancer Database. Journal Of The American College Of Surgeons 2015, 220: 1063-1069. PMID: 25868410, DOI: 10.1016/j.jamcollsurg.2015.02.011.Peer-Reviewed Original ResearchConceptsNational Cancer DatabaseNeoadjuvant chemotherapyBreast preservationBreast conservationTumor sizeCancer DatabaseDefinitive breast surgerySmall institutional seriesBreast cancer increasesAdvanced nodal diseaseInvasive breast cancerYounger patient ageBreast tumor sizeLarger tumor sizeMultivariate logistic regressionHigh tumor gradeAmerican Cancer SocietyAdjuvant chemotherapyNodal diseasePrimary surgeryT4 tumorsInstitutional seriesPatient ageRetrospective reviewDistant metastasisGrowing Use of Mastectomy for Ductal Carcinoma-In Situ of the Breast Among Young Women in the United States
Rutter CE, Park HS, Killelea BK, Evans SB. Growing Use of Mastectomy for Ductal Carcinoma-In Situ of the Breast Among Young Women in the United States. Annals Of Surgical Oncology 2015, 22: 2378-2386. PMID: 25564175, DOI: 10.1245/s10434-014-4334-x.Peer-Reviewed Original ResearchConceptsContralateral prophylactic mastectomyUse of mastectomyYounger patientsHigh-risk histopathologic featuresNational Cancer Data BaseGreater medical comorbidityRate of mastectomyYounger patient ageBreast conservation therapyMultivariable logistic regressionHigh tumor gradeProportion of womenBackgroundDuctal carcinomaPreinvasive formExtensive diseaseMastectomy ratesMedical comorbiditiesPatient ageConservation therapyDuctal carcinomaHistopathologic featuresExcellent outcomesProphylactic mastectomySurgical choiceTumor grade
1998
Prognostic value of prostate-specific antigen for women with breast cancer: a large United States cohort study.
Yu H, Levesque M, Clark G, Diamandis E. Prognostic value of prostate-specific antigen for women with breast cancer: a large United States cohort study. Clinical Cancer Research 1998, 4: 1489-97. PMID: 9626467.Peer-Reviewed Original ResearchMeSH KeywordsAdultAgedAged, 80 and overAnalysis of VarianceBiomarkers, TumorBreast NeoplasmsCohort StudiesCytosolFemaleFollow-Up StudiesHumansLymphatic MetastasisMiddle AgedPloidiesPrognosisProstate-Specific AntigenReceptors, EstrogenReceptors, ProgesteroneS PhaseSurvival AnalysisTime FactorsUnited StatesConceptsProstate-specific antigenPrimary breast cancerBreast cancerCohort studyPrognostic valueRelative riskBreast tumorsSteroid hormone receptor levelsLow S-phase fractionMeasurement of PSAPSA-negative patientsPSA-positive patientsPrognosis of patientsYounger patient ageHormone receptor levelsLarge cohort studyUnited States cohort studyValuable tumor markerS-phase fractionUnited States patientsBreast tumor extractsMedian followPSA presenceNodal statusPatient age
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply